Relay Therapeutics lands $63 mln Series B
Cambridge, Massachusetts-based Relay Therapeutics, a biotech company, has closed $63 million in Series B financing. BVF Partners led the round with participation from GV, Casdin Capital, EcoR1 Capital, Section 32, Third Rock Ventures and Alexandria Venture Investments. In conjunction with the funding, Kanishka Pothula, a managing director at BVF Partners, will join Relay Therapeutics' board of directors.
14 December 2017•1 min read
